{"address1": "1000 Alfred Nobel Drive", "city": "Hercules", "state": "CA", "zip": "94547", "country": "United States", "phone": "510 724 7000", "fax": "510 741 5817", "website": "https://www.bio-rad.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.", "fullTimeEmployees": 7700, "companyOfficers": [{"maxAge": 1, "name": "Mr. Norman D. Schwartz", "age": 74, "title": "Chairman & CEO", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 1451580, "exercisedValue": 0, "unexercisedValue": 1493570}, {"maxAge": 1, "name": "Mr. Jonathan P. DiVincenzo", "age": 58, "title": "President & COO", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1860703, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Crowley", "age": 62, "title": "Executive Vice President of Global Commercial Operations", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 649798, "exercisedValue": 360069, "unexercisedValue": 514650}, {"maxAge": 1, "name": "Ms. Anette  Engelhardt", "title": "Executive VP & President of the Clinical Diagnostics Group", "fiscalYear": 2024, "totalPay": 401446, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yong  Chung", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Matthew  Werner", "title": "Senior Vice President and Chief Compliance & Privacy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Courtney C. Enloe", "title": "Executive VP, General Counsel & Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Colleen  Corey", "age": 62, "title": "Executive Vice President of Global Human Resources", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lee  Boyd", "title": "Senior Vice President of Global Commercial Operations - Asia Pacific", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James J. Barry", "title": "Executive VP & President of Life Science Group", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 9, "compensationRisk": 6, "shareHolderRightsRisk": 10, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 243.56, "open": 242.7, "dayLow": 237.9175, "dayHigh": 245.23, "regularMarketPreviousClose": 243.56, "regularMarketOpen": 242.7, "regularMarketDayLow": 237.9175, "regularMarketDayHigh": 245.23, "payoutRatio": 0.0, "beta": 0.985, "forwardPE": 20.600859, "volume": 348064, "regularMarketVolume": 348064, "averageVolume": 296075, "averageVolume10days": 433410, "averageDailyVolume10Day": 433410, "bid": 225.8, "ask": 288.5, "bidSize": 8, "askSize": 8, "marketCap": 6732768256, "fiftyTwoWeekLow": 235.84, "fiftyTwoWeekHigh": 387.99, "priceToSalesTrailing12Months": 2.6233268, "fiftyDayAverage": 290.7374, "twoHundredDayAverage": 317.25024, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6432873984, "profitMargins": -0.71857, "floatShares": 20420963, "sharesOutstanding": 22940800, "sharesShort": 1003041, "sharesShortPriorMonth": 609993, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0358, "heldPercentInsiders": 0.15578, "heldPercentInstitutions": 0.84693, "shortRatio": 2.59, "shortPercentOfFloat": 0.057800002, "impliedSharesOutstanding": 28053200, "bookValue": 234.525, "priceToBook": 1.0233451, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -1844199936, "trailingEps": -65.35, "forwardEps": 11.65, "lastSplitFactor": "2:1", "lastSplitDate": 1015545600, "enterpriseToRevenue": 2.506, "enterpriseToEbitda": 15.295, "52WeekChange": -0.26869398, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 240.0, "targetHighPrice": 447.0, "targetLowPrice": 285.0, "targetMeanPrice": 367.83334, "targetMedianPrice": 377.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 1664499968, "totalCashPerShare": 59.423, "ebitda": 420600000, "totalDebt": 1374700032, "quickRatio": 4.553, "currentRatio": 6.478, "totalRevenue": 2566500096, "debtToEquity": 20.926, "revenuePerShare": 90.965, "returnOnAssets": 0.015520001, "returnOnEquity": -0.24091, "grossProfits": 1378899968, "freeCashflow": 180862496, "operatingCashflow": 455200000, "revenueGrowth": -0.02, "grossMargins": 0.53727, "ebitdaMargins": 0.16388, "operatingMargins": 0.086789995, "financialCurrency": "USD", "symbol": "BIO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Bio-Rad Laboratories, Inc.", "longName": "Bio-Rad Laboratories, Inc.", "corporateActions": [], "preMarketTime": 1743596579, "regularMarketTime": 1743537602, "exchange": "NYQ", "messageBoardId": "finmb_255743", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.46165, "regularMarketPrice": 240.0, "marketState": "PRE", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 296075, "fiftyTwoWeekLowChange": 4.1600037, "fiftyTwoWeekLowChangePercent": 0.017639093, "fiftyTwoWeekRange": "235.84 - 387.99", "fiftyTwoWeekHighChange": -147.98999, "fiftyTwoWeekHighChangePercent": -0.38142735, "fiftyTwoWeekChangePercent": -26.869398, "earningsTimestamp": 1739481600, "earningsTimestampStart": 1746475200, "earningsTimestampEnd": 1746820800, "earningsCallTimestampStart": 1739484000, "earningsCallTimestampEnd": 1739484000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -65.35, "epsForward": 11.65, "epsCurrentYear": 9.57586, "priceEpsCurrentYear": 25.063023, "fiftyDayAverageChange": -50.737396, "fiftyDayAverageChangePercent": -0.1745128, "twoHundredDayAverageChange": -77.250244, "twoHundredDayAverageChangePercent": -0.2434994, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 320509800000, "preMarketChange": -2.0, "preMarketChangePercent": -0.8333333, "preMarketPrice": 238.0, "regularMarketChange": -3.56, "regularMarketDayRange": "237.9175 - 245.23", "displayName": "Bio-Rad Laboratories", "trailingPegRatio": null}